Dr. Robert O Wayment , MD
Urology • Ogden, UT
4700 Harrison Blvd
Ogden, UT 844034303
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on May 2, 2007; this date does not establish years in practice.
-
Published CMS data list 1,954.7 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 52000 — Diagnostic exam of bladder and urethra using an endoscope: 244 service units.
- 99213 — Established patient outpatient office visit: 179 service units.
- 36415 — Insertion of needle into vein for collection of blood sample: 144 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 34 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 1,720 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Tamsulosin Hcl — 345 prescription fills, including refills.
- Finasteride — 284 prescription fills, including refills.
- Orgovyx (Relugolix) — 223 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 21 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 70% of clinicians listed under Urology in Utah (2024, 63 clinicians with data). Median for this group: 860. Middle half: 470 to 2,728.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 2,549 in 2020 to 1,954.7 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
4700 Harrison Blvd
Ogden, UT 844034303
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Ogden Clinic Specialty Services Llc. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
University Of Utah School Of Medicine
2005
What Public CMS Data Show
Urology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
481 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $196,737 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $153,687 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
3,100 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$2,899,367 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $2,009.66 across 66 records.
By nature of payment
- Food and Beverage: $1,811.66 across 64 records.
- Education: $198.00 across 2 records.
Reporting-company totals (3 largest of 23)
- Boston Scientific Corporation: $536.48 across 14 records.
- Astellas Pharma US Inc: $269.21 across 6 records.
- Calyxo, Inc.: $238.11 across 3 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
21 years (graduated 2005)
CMS Doctors and Clinicians data list 2005 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2007
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Wayment has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Wayment as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Ogden and Utah
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 70% of clinicians listed under Urology in Utah (2024, 63 clinicians with data). Median for this group: 860. Middle half: 470 to 2,728.
Too few clinicians listed under Urology in Ogden have Medicare Part B data for 2024 to compare.
Medicare-allowed amount
A higher Medicare-allowed amount than 85% of clinicians listed under Urology in Utah (2024, 63 clinicians with data). Median for this group: $76,622. Middle half: $49,199 to $141,065.
Too few clinicians listed under Urology in Ogden have Medicare Part B data for 2024 to compare.
Paid by Medicare
A higher Medicare payment amount than 85% of clinicians listed under Urology in Utah (2024, 63 clinicians with data). Median for this group: $58,344. Middle half: $34,877 to $104,002.
Too few clinicians listed under Urology in Ogden have Medicare Part B data for 2024 to compare.
Medicare Part D prescriptions
More Part D prescriptions than 85% of clinicians listed under Urology in Utah (2024, 75 clinicians with data). Median for this group: 622. Middle half: 136 to 1,247.
Too few clinicians listed under Urology in Ogden have Medicare Part D data for 2024 to compare.
Part D drug cost
A higher Part D drug cost than 95% of clinicians listed under Urology in Utah (2024, 75 clinicians with data). Median for this group: $44,201. Middle half: $3,752 to $114,433.
Too few clinicians listed under Urology in Ogden have Medicare Part D data for 2024 to compare.
6 active clinicians are listed under Urology with a practice address in Ogden, UT (105 in Utah).
Addresses are self-reported to NPPES and may be out of date.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services decreased 23% from 2,549 in 2020 to 1,954.7 in 2024.
- 2020: 2,549
- 2021: 2,395
- 2022: 3,115
- 2023: 2,444.7
- 2024: 1,954.7
-
Medicare-allowed amount
Medicare-allowed amount decreased 15% from $230,152 in 2020 to $196,737 in 2024.
- 2020: $230,152
- 2021: $214,846
- 2022: $267,406
- 2023: $239,420
- 2024: $196,737
-
Paid by Medicare
Paid by Medicare decreased 13% from $177,150 in 2020 to $153,687 in 2024.
- 2020: $177,150
- 2021: $165,543
- 2022: $203,510
- 2023: $186,567
- 2024: $153,687
-
Medicare Part D prescriptions
Medicare Part D prescriptions stayed about the same: 1,716 in 2020 and 1,720 in 2024.
- 2020: 1,716
- 2021: 1,441
- 2022: 1,773
- 2023: 1,730
- 2024: 1,720
-
30-day fills
30-day fills stayed about the same: 3,236 in 2020 and 3,100 in 2024.
- 2020: 3,236
- 2021: 2,700
- 2022: 3,324
- 2023: 3,151
- 2024: 3,100
-
Part D drug cost
Part D drug cost increased 1796% from $152,948 in 2020 to $2,899,367 in 2024.
- 2020: $152,948
- 2021: $396,417
- 2022: $1,398,451
- 2023: $2,140,030
- 2024: $2,899,367
-
Industry payments (Open Payments)
Industry payments (Open Payments) decreased 50% from $4,041.42 in 2021 to $2,009.66 in 2025.
- 2021: $4,041.42
- 2022: $114,353.02
- 2023: $1,356.29
- 2024: $828.13
- 2025: $2,009.66
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 66 records totaling $2,009.66.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Boston Scientific Corporation |
Food and Beverage
In-kind items and services
|
Rezum Generator | General | $132.77 |
| Dornier MedTech America, Inc |
Food and Beverage
In-kind items and services
|
Dornier MedTech | General | $109.54 |
| Astellas Pharma US Inc |
Education
In-kind items and services
|
— | General | $99.00 |
| Astellas Pharma US Inc |
Education
In-kind items and services
|
— | General | $99.00 |
| Calyxo, Inc. |
Food and Beverage
In-kind items and services
|
CVAC ASPIRATION SYSTEM | General | $88.41 |
| Calyxo, Inc. |
Food and Beverage
In-kind items and services
|
CVAC ASPIRATION SYSTEM | General | $82.46 |
| Boston Scientific Corporation |
Food and Beverage
In-kind items and services
|
LithoVue | General | $75.75 |
| Calyxo, Inc. |
Food and Beverage
In-kind items and services
|
CVAC ASPIRATION SYSTEM | General | $67.24 |
| Boston Scientific Corporation |
Food and Beverage
In-kind items and services
|
LithoVue | General | $57.13 |
| Boston Scientific Corporation |
Food and Beverage
In-kind items and services
|
LithoVue | General | $52.82 |
| Boston Scientific Corporation |
Food and Beverage
In-kind items and services
|
LithoVue | General | $47.06 |
| Boston Scientific Corporation |
Food and Beverage
In-kind items and services
|
SpaceOAR VUE System - 10mL | General | $46.85 |
| Laborie Medical Technologies Corp. |
Food and Beverage
Cash or cash equivalent
|
— | General | $45.18 |
| KARL STORZ Endoscopy-America |
Food and Beverage
In-kind items and services
|
— | General | $32.91 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
XTANDI | General | $26.63 |
| Dendreon Pharmaceuticals LLC |
Food and Beverage
In-kind items and services
|
PROVENGE | General | $26.46 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $26.11 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
XTANDI | General | $23.82 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $23.61 |
| UROGEN PHARMA, INC. |
Food and Beverage
In-kind items and services
|
JELMYTO | General | $23.33 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
IMFINZI | General | $23.14 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
XTANDI | General | $23.00 |
| Boston Scientific Corporation |
Food and Beverage
In-kind items and services
|
Tria Firm | General | $22.91 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $21.91 |
| CIVCO Medical Instruments |
Food and Beverage
Cash or cash equivalent
|
— | General | $21.81 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
52000
Diagnostic exam of bladder and urethra using an endoscope
|
244 | 218 | $441.00 | $221.32 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
179 | 152 | $133.00 | $84.82 |
|
36415
Insertion of needle into vein for collection of blood sample
|
144 | 122 | $7.00 | $6.86 |
|
87086
Bacterial colony count, urine
|
123 | 89 | $20.00 | $7.86 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
120 | 99 | $182.00 | $120.32 |
|
84153
Psa (prostate specific antigen) measurement, total
|
106 | 91 | $46.00 | $18.02 |
|
J2250
Injection, midazolam hydrochloride, per 1 mg
|
66.7 | 16 | $1.89 | $0.14 |
|
87186
Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution
|
59 | 43 | $21.00 | $8.36 |
|
74420
Imaging of urinary tract following injection of a contrast agent
|
57 | 45 | $115.77 | $22.67 |
|
96372
Injection of drug or substance under skin or into muscle
|
57 | 35 | $37.00 | $13.20 |
|
87088
Bacterial urine culture
|
55 | 40 | $18.00 | $7.81 |
|
99203
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
|
55 | 55 | $167.00 | $104.70 |
|
G2211
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
|
54 | 49 | $24.00 | $15.40 |
|
76872
Ultrasound scan of pelvic region through rectum
|
53 | 52 | $315.00 | $123.19 |
|
81002
Urinalysis, manual test
|
50 | 47 | $8.00 | $3.34 |
|
55700
Biopsy of prostate gland
|
48 | 47 | $445.00 | $220.98 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
48 | 48 | $254.00 | $158.95 |
|
64566
Insertion of lower leg neurostimulator electrode
|
44 | 13 | $268.00 | $107.50 |
|
51798
Ultrasound measurement of bladder capacity after voiding
|
39 | 34 | $39.00 | $10.08 |
|
52332
Insertion of stent in ureter using an endoscope
|
32 | 27 | $1140.66 | $98.77 |
|
81001
Manual urinalysis test with examination using microscope, automated
|
32 | 17 | $8.00 | $3.03 |
|
51702
Simple insertion of temporary bladder tube
|
30 | 13 | $146.00 | $57.91 |
|
52310
Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope
|
29 | 27 | $527.00 | $292.48 |
|
51784
Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings
|
28 | 28 | $178.26 | $20.48 |
|
51728
Complex measurement of pressure of urine flow in bladder with voiding pressure studies
|
26 | 26 | $265.85 | $126.43 |
(top 25 shown)
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Tamsulosin Hcl | Tamsulosin Hcl | 345 | 27,936 | $6,044.74 | 131 |
| Finasteride | Finasteride | 284 | 21,877 | $2,997.57 | 87 |
| Orgovyx | Relugolix | 223 | 6,690 | $587,669.63 | 31 |
| Cefuroxime | Cefuroxime Axetil | 172 | 676 | $1,246.42 | 146 |
| Xtandi | Enzalutamide | 156 | 4,680 | $2,198,747.96 | 17 |
| Myrbetriq | Mirabegron | 82 | 3,936 | $58,609.43 | 23 |
| Methenamine Hippurate | Methenamine Hippurate | 63 | 3,620 | $6,044.83 | 21 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 54 | 91 | $159.34 | 50 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 45 | 420 | $278.19 | 37 |
| Solifenacin Succinate | Solifenacin Succinate | 45 | 2,620 | $1,063.24 | 17 |
| Trospium Chloride Er | Trospium Chloride | 41 | 2,570 | $9,242.10 | 13 |
| Silodosin | Silodosin | 36 | 1,740 | $1,537.88 | 11 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 35 | 133 | $121.68 | 32 |
| Potassium Citrate Er | Potassium Citrate | 31 | 2,400 | $3,637.15 | — |
| Gemtesa | Vibegron | 24 | 1,240 | $19,698.44 | 12 |
| Trospium Chloride | Trospium Chloride | 21 | 1,024 | $1,278.54 | — |
| Levofloxacin | Levofloxacin | 17 | 149 | $47.31 | 14 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 13 | 810 | $145.16 | — |
| Doxycycline Hyclate | Doxycycline Hyclate | 11 | 147 | $133.99 | — |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 11 | 930 | $212.27 | — |
| Dutasteride | Dutasteride | 11 | 750 | $451.50 | — |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 208800000X
A urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - UROLOGY
I20100802000852
UT
5395878011
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Ogden Clinic Specialty Services Llc
4700 Harrison Blvd, Ogden, UT 844034303
Phone: 8014753300
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Nurse Practitioner
Urology
Doctor of Medicine (M.D.)
Physician Assistant
Physician Assistant (Certified)
Nurse Practitioner
Nurse Practitioner (Certified)
Urology
Doctor of Medicine (M.D.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
NPI status registered as active in NPPES database
Registered at PO BOX 5546, DENVER, CO 802175546 (Tel: 8014753160)
Registered at 4700 HARRISON BLVD, OGDEN, UT 844034303 (Tel: 8014753160)
Recorded as ROBERT WAYMENT, MD
Urology (license number reported to NPPES: UT 7577068-1205)
NPI status registered as active in NPPES database
Registered at 4700 HARRISON BLVD, OGDEN, UT 844034303 (Tel: 8014753160)
Registered at 4650 HARRISON BLVD, OGDEN, UT 844034303 (Tel: 8014753000)
Recorded as ROBERT WAYMENT, MD
Urology (license number reported to NPPES: UT 7577068-1205)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Urology Specialists in Ogden
- Dr. Curtis Campbell, MD
- Dr. Bradford Stevenson, MD
- Dr. Brian Heaton, MD PC
- Dr. Tyler Christensen, MD
Mailing Address
Po Box 5546
Denver, CO 802175546
Phone: 8014753160